secwatch.observer — SEC 8-K summary
======================================

Issuer:     SBC Medical Group Holdings Inc (SBC)
CIK:        0001930313
Form:       8-K
Filed at:   2025-04-02T23:59:59+00:00
Accession:  0001641172-25-002370
Event type: leadership
Sentiment:  neutral
Materiality: 0.35
Item codes: 5.02
LLM model:  deepseek-v4-flash:cloud@v2

SBC Medical names Miki Shimizu as Chief Strategy Officer; Komatsu moves to Japan sub role
--------------------------------------------------------------------------------

- Board approved on March 27, 2025; effective April 10, 2025.
- Miki Shimizu will become Chief Strategy Officer, replacing Akira Komatsu.
- Akira Komatsu transitions to Chief of Group Representative Office for SBC Medical Group Co., Ltd. (Japan).
- Both roles are within SBC Medical Group Holdings Incorporated or its subsidiary.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1930313/000164117225002370/0001641172-25-002370-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1930313/000164117225002370/form8-k.htm
  HTML page:      https://secwatch.observer/filing/0001641172-25-002370

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer